US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Nymox Pharmaceutical Corp (PK) (NYMXF)
Nymox Pharmaceutical Corp (PK) (NYMXF) ニュース

Nymox Pharmaceutical Corp (PK) (NYMXF)

0.12

0.00

( 0.00% )

更新日時： 00:47:14

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

Nymox's Nymozarfex(TM) Newly Available for Prostate Treatments for Medical Tourists in Collaboration with the Global Alliance of Regenerative Medicine on Roatan Island in the Caribbean

IRVINE, CA / ACCESS Newswire / June 17, 2026 / Nymox Pharmaceutical Corporation ("Nymox", "The Company") (OTCQB:NYMXF) is...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

NYMOX Provides Current Update

IRVINE, CA / ACCESS Newswire / June 2, 2026 / Nymox Pharmaceutical Corporation ("Nymox", "The Company") (OTCQB:NYMXF) reports...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

NYMOX Provides Recent Updates

IRVINE, CA / ACCESS Newswire / March 27, 2026 / Nymox Pharmaceutical Corporation ("Nymox", "The Company") (OTCQB:NYMXF) will...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form NT 20-F - Notification of inability to timely file Form 20-F

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Renee

NYMX changed to NYMXF. Delisted from the Nasdaq to the OTC:

https://otce.finra.org/otce/dailyList?viewType=Additions

Triple nickle

Triple nickle 3年前

Spicknspan

Spicknspan 3年前

A one time injectable treatment for an enlarged prostate would have a huge market. Bought a few here so I know I will keep an eye on the news.

Suds Mackenzie

Suds Mackenzie 5年前

NDA not coming soon?

Suds Mackenzie

Suds Mackenzie 5年前

NDA Coming soon?

Suds Mackenzie

Suds Mackenzie 5年前

Up today on NO news?

Suds Mackenzie

Suds Mackenzie 5年前

Delays and more delays and now more dilution. $.50 coming soon.

Suds Mackenzie

Suds Mackenzie 5年前

Will NYMX file NDA by 9/15/21?

lytnup

Less than a month away.

Nymox Announces Date for Fexapotide Filing
NEWS RELEASE
HASBROUCK HEIGHTS, NJ (May 6, 2021) Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce that it will be filing for marketing approval of Fexapotide Triflutate for BPH before the end of the summer, on or before 15 September 2021.
CEO Dr Paul Averback said, "The Company will file on or before September 15. We hope but cannot be certain that the date may be before September. Company management will communicate updates where appropriate."

https://nymox.com/files/download/45b2b195922068b

Suds Mackenzie

Suds Mackenzie 5年前

2ND QUARTER RESULTS DISSAPOINTING AS USUAL. STILL NO UPDATES ON NDA.

Suds Mackenzie

Suds Mackenzie 5年前

NDA appication coming soon? I have my doubts.

Suds Mackenzie

Suds Mackenzie 5年前

Suds Mackenzie

Suds Mackenzie 5年前

Director - James G Robinson just picked up 38,000 shares. This was his first purchase in over a 1 1/2 years and he now owns 3,550,550 shares. He has done this many times and usually buys when it drops to around $2 or less. He is 85 years old now and God Bless he lives long enough to see this drug get FDA approval and come to market.

stillchillin

stillchillin 5年前

Who is buying today?? Is it GR loading up in front of good news? He has a boat load and has been holding for a while

wesley_

wesley_ 5年前

$2.48 picked some up

Suds Mackenzie

Suds Mackenzie 5年前

Good news or bad? The clock is ticking!

Suds Mackenzie

Suds Mackenzie 5年前

Going down down down down down!

Suds Mackenzie

Suds Mackenzie 5年前

ANOTHER NICE DAY!

Suds Mackenzie

Suds Mackenzie 5年前

BIG NEWS COMING IN Q1.

Suds Mackenzie

Suds Mackenzie 6年前

Suds Mackenzie

Suds Mackenzie 6年前

NDA - Ist quarter 2021, could it finally happen?

Suds Mackenzie

Suds Mackenzie 6年前

Big news coming soon?

Suds Mackenzie

Suds Mackenzie 6年前

The year is almost over and still no significant news!

Suds Mackenzie

Suds Mackenzie 6年前

What is taking so long???

Suds Mackenzie

Suds Mackenzie 6年前

NDA NDA NDA NDA ?

Suds Mackenzie

Suds Mackenzie 6年前

Even more dilution???

Suds Mackenzie

Suds Mackenzie 6年前

NEWS TODAY. GOOD, BAD OR SAME OLD SAME OLD.

Suds Mackenzie

Suds Mackenzie 6年前

More dilution - $12,000,000 stock offering.

https://ih.advfn.com/stock-market/NASDAQ/nymox-pharmaceutical-NYMX/stock-news/82880626/prospectus-filed-pursuant-to-rule-424b5-424b5

Suds Mackenzie

Suds Mackenzie 6年前

Starting to turn Bearish on this.

Suds Mackenzie

Suds Mackenzie 6年前

Will NYMX ever succeed?

Suds Mackenzie

Suds Mackenzie 6年前

NDA ?? I will believe it when I see it.

Suds Mackenzie

Suds Mackenzie 6年前

Dog and pony show continues.

Suds Mackenzie

Suds Mackenzie 6年前

Tick Tick Tick....

Suds Mackenzie

Suds Mackenzie 6年前

Hopefully good news coming soon.

Suds Mackenzie

Suds Mackenzie 6年前

What's the holdup?

Suds Mackenzie

Suds Mackenzie 6年前

$12,000,000. STOCK OFFERING.

https://ih.advfn.com/stock-market/NASDAQ/nymox-pharmaceutical-NYMX/stock-news/82306706/securities-registration-foreign-private-issuer-f-3

Suds Mackenzie

Suds Mackenzie 6年前

Even the Coronavirus can't keep NYMX down.

Suds Mackenzie

Suds Mackenzie 6年前

Hope this drops under $2, I will stock up.

Suds Mackenzie

Suds Mackenzie 6年前

Lots of news lately. Hoping for the NDA soon.

tayronachan

tayronachan 6年前

But will they have anything to offer in helping stop the new corona virus, or helping the victims?
Any of this?..........."The Company has research interests in protein markers, subcellular pathology, cell death, cell proliferation, clinical models, genetic expression, morphology, and drug screening design, assays, and development. Nymox maintains an active interest in scientific collaborations and has a lengthy history of working together with prominent researchers around the world."

zumantu

zumantu 6年前

Suds Mackenzie

Suds Mackenzie 6年前

Tick, tick, tick, tick.

Suds Mackenzie

Suds Mackenzie 6年前

Nymox Announces New Peer Review Article on Fexapotide Pharmaco-Ablation Experimental Studies Published in Research and Report...

yankees18

yankees18 7年前

Suds Mackenzie

Suds Mackenzie 7年前

Happy New Year for NYMX.

Suds Mackenzie

Suds Mackenzie 7年前

Fraud, Failure or Look for NDA in 2020

Suds Mackenzie

Suds Mackenzie 7年前

As at November 15, 2019, 69,968,706 common shares without par value of the Corporation were outstanding.

Suds Mackenzie

Suds Mackenzie 7年前

RESULTS FORTHCOMING.

Suds Mackenzie

Suds Mackenzie 7年前

2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020

zumantu

zumantu 7年前

Did I miss the big news?

Nymox Pharmaceutical (PK)

Intsanpaolo Tf 2,1% Nv30...

DIFJ28V28 - 04/2028

coupon of 3.125%

Bmo Us Dollar Balanced F...

Enka Insaat Ve Sanayi AS (PK)

FTSEurofirst 300 Food Be...

Zapata Computing

International bond 5.125...

T Rowe Price US High Yie...

FTSE USA Large Cap Super...

SIM Acquisiiton Corporat...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。